BostonGene Stock

bostongene.comHealthcareFounded: 2015Funding to Date: $200MM

BostonGene’s mission is to power healthcare’s transition to personalized medicine using AI-based molecular and immune profiling to improve the standard of care, accelerate research, and improve economics. The BostonGene Tumor Portrait Test, a comprehensive integrated genomic and transcriptomic analysis of tumors and the microenvironment, reveals key drivers of each tumor. This company was founded in 2015 by Andrew Feinberg and is headquartered in Boston, MA.

Register for Details

For more details on financing and valuation for BostonGene, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for BostonGene.

Register Today

Other companies like BostonGene in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector
 
 
Sector
Last Round Est. Valuation
$500MM